Connect with us

Health

Brisbane biotech company trials drug on US COVID-19 patients in bid to find ‘new way to prevent people dying’ of virus – ABC News

A Brisbane biotech company creates an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States…

Published

on

Article feature image
ADVERTISEMENT

A Brisbane biotech company, led by award-winning immunologist Ian Frazer, has created an anti-inflammatory drug, which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States.
Key points:

  • The drug is being trailed on 300 people in the US, with results expected in about six months
  • If successful, drug IC14 could become part of routine care to treat COVID-19 patients with severe infection
  • Professor Ian Frazer says the drug could provide a new way to treat people…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Next two weeks critical to preventing a COVID-19 outbreak in NSW – ABC News
Article feature image
Sleeping six to seven hours a night associated with more favorable heart health – News-Medical.Net